Vascular Biology |
From the Petit Institute for Bioengineering and Bioscience (J.T.B., T.J., R.M.N.) and Woodruff School of Mechanical Engineering (J.T.B., R.M.N.), Georgia Institute of Technology, Atlanta; Coulter Department of Biomedical Engineering (S.T., G.S., H.J.), and Division of Cardiology, Georgia Tech and Emory University, Atlanta; and Cardiovascular Developmental Biology Center (J.T.B., D.T.), Childrens Research Institute, Medical University of South Carolina, Charleston.
Correspondence to Robert M. Nerem, Petit Institute for Bioengineering and BioscienceIBB, 315 Ferst Dr, Atlanta, GA 30332 (E-mail Robert.nerem{at}ibb.gatech.edu); or Janjoong Jo, PhD, Associate Professor, Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, 308D Woodruff Memorial Building, 1639 Pierce Dr, Atlanta, GA 30322-4600 (E-mail hanjoong.jo@bme.gatech.edu)
| Abstract |
|---|
|
|
|---|
Methods and Results Monolayers of porcine aortic endothelial cells (PAECs) or porcine aortic valve endothelial cells (PAVECs) were exposed to 20 dyne/cm2 steady laminar shear stress for 48 hours, with static cultures serving as controls. Multiple microarray comparisons were made using RNA from sheared and control batches of both cell types. More than 400 genes were significantly differentially expressed in each comparison group. The resulting profiles were validated at the transcription and protein level and expression patterns confirmed in vivo by immunohistochemistry. PAVECs were found to be less intrinsically inflammatory than PAECs, but both cell types expressed similar antioxidant and antiinflammatory genes in response to shear stress. PAVECs expressed more genes associated with chondrogenesis, whereas PAECs expressed osteogenic genes, and shear stress had a protective effect against calcification.
Conclusions Transcriptional differences between PAVECs and PAECs highlight the valvular endothelial cell as a distinct organ system and suggest more attention needs to be given to valvular cells to further our understanding of similarities and differences between valvular and vascular pathology.
Aortic and aortic valve endothelial cell gene expression was compared in static and steady shear environments. Transcriptional profiles suggested that valvular endothelial cells are similar in some respects but distinct in other ways that may have important implications for the understanding of valvular pathology and therapeutic strategies.
Key Words: aortic valve shear stress inflammation calcification endothelial cell
| Introduction |
|---|
|
|
|---|
The vascular endothelium is a critical mediator of hemodynamic and humoral stimuli, and that endothelial inflammation and atherosclerosis occur preferentially at sites of disturbed or oscillatory flow.9 Valvular endothelial dysfunction is also a hallmark of leaflet degeneration, and similarly characterized by the expression of proinflammatory adhesion receptors.10,11 Interestingly, much of the aforementioned valvular pathology seems to occur preferentially on the aortic surface of the leaflet, which experiences a complex circulating flow that is different from the unidirectional flow on the ventricular side of the leaflet. This suggests that disturbed flow may play a causal role in the initiation of valvular pathology through activation of valvular endothelium, and likewise that valvular endothelium may be protected from dysfunctional activation by unidirectional flow, but as yet, no studies have been done to investigate this.
We have previously shown that valvular endothelial cells respond to shear stress by aligning perpendicular to the direction of flow, this in contrast to vascular endothelial cells, which align parallel to flow.12 This alignment was associated with differences in focal adhesion arrangement and differential involvement of signal kinases, suggesting that these different endothelial cell types may interpret mechanical signals heterogeneously.
The objective of this article, therefore, is to characterize the similarities and differences between these endothelial populations through transcriptional profiles in static and shear conditions and identify putative mechanosensitive proteins that may be involved in the regulation of these differences. The resulting expression profiles suggest that valvular endothelium are similarly protected from oxidative stress, inflammatory stress, and calcification by shear stress, but intrinsic differences in the susceptibilities of these cells to the aforementioned pathologies may exist.
| Materials and Methods |
|---|
|
|
|---|
Transcript Profiling Studies and Data Analyses
Four experimental groups were created for gene expression comparison: group 1 included PAVEC shear versus PAVEC static; group 2 included PAEC shear versus static; group 3 included PAVEC static versus PAEC static; and group 4, PAVEC shear versus PAEC shear (Figure I, available online at http://atvb.ahajournals.org). After shear or static conditions, total RNA was extracted from cell pellets pooled from 2 identical and independent experiments using the RNeasy mini column (Qiagen). Ten micrograms total RNA pools from 2 different experimental conditions were independently and randomly labeled with either Cy3 or Cy5 fluorophores using the Agilent Fluorescent Direct Label kit (Agilent Technologies). Labeled RNA pools were then competitively hybridized to Agilent Human 1 cDNA microarray slides (Agilent #G4100A), which contain 2 identical array areas. The above procedures were repeated 3 times using a different cell isolation batch each time, giving 6 arrays in an n=3 (biological replicates), n=2 (technical replicates) arrangement for each comparison group, for a total of 24 arrays. Fluorescence intensities of each hybridized spot were determined by using the Agilent Array Scanner and the Agilent Feature Extraction Software.13 Two different statistical methods were used to determine differentially expressed genes: mixed ANOVA (MxANOVA) and significance analysis of microarrays (SAM).14,15 The list of differentially expressed genes in each comparison group was analyzed for statistically enriched or depleted biological classifications using the GoMiner database engine.16 Additional details are provided in the methods supplement.
Quantitative Real-Time RT-PCR, Western Blots, and Immunostaining
The expression trends of a panel of genes were confirmed at the transcript (quantitative real-time RT-PCR [QRT-PCR]) and protein levels (Western blot) using additional samples not used in the microarrays. Additional normal adult porcine valve leaflets and aortic wall tissue were excised, fixed in 10% neutral buffered formalin, paraffin embedded, and sectioned at 5 µm. Immunohistochemistry was performed for selected genes as indicated in the results using fluorescence-based detection methods (see online supplement).
| Results |
|---|
|
|
|---|
We next validated some of the microarray data at the mRNA and protein levels by QRT-PCR and Western blots, respectively (Figure 1). Based on the microarray data, we initially chose 3 known shear-regulated genes. Bone morphogenic protein 4 (BMP-4) downregulation in response to shear as shown by the microarray analysis was confirmed in both cell types and in each method (P<0.05; Figure 1A). Cytochrome P450 peptide 1A1 (CYP1A1) upregulation found in the microarray analysis (&10-fold) by shear was also confirmed by QRT-PCR in both cell types (P<0.05), although the protein level was upregulated to a much smaller degree (1.6-fold upregulation; Figure 1B). As shown in Figure 1C, caveolin-1 (CAV-1) gene transcript level determined by the microarray was not affected by shear in PAECs but was downregulated by shear in PAVECs. However, QRT-PCR and Western blot studies showed that shear exposure decreased the mRNA and protein expression levels by 2.6 and 1.7-fold, respectively (P<0.05; Figure 1C).
|
We further confirmed the array data by Western blots for 2 additional genes: periostin (POSTN) and cadherin 11 (CAD11), in both cell types exposed to static and shear conditions (Figure 2). In total, the microarray trends were confirmed in 9 of 10 cases (BMP-4, CYP1A1, POSTN, and CAD11 in both cell types and CAV1 in PAVECs) but not in 1 case (CAV1 in PAECs) by QRT-PCR and Western blotting (Figures 1 and 2
).
|
In addition, we validated the in vitro results in intact aortic valve (AV) tissues of normal pigs by immunohistochemical staining. We first used endothelial NO synthase (eNOS) as a positive control for endothelial cells and shear responses, although its transcript levels in our array studies could not be analyzed because of poor quality of some of the spots. The eNOS is expressed in the endothelium of the aorta and both sides of the aortic valve with higher expression at the ventricularis surface, where shear stress is believed to be more stable and unidirectional than that of fibrosa. BMP-4 was detected on the endothelium of normal aortas and valves (Figure 3). Expression was greater on the fibrosa side of the leaflet. Vascular cell adhesion molecule 1 (VCAM1) was not detected on normal aorta or aortic valves (data not shown). These results are similar to our previous report with aortic endothelial cells in response to laminar or oscillatory shear stresses.17
|
Analysis of Biological Classifications
The coordinated overexpression or underexpression of a group of genes in an ontological category may indicate certain functional responses to shear stress or differences between cell types. Biological classifications related to several important known endothelial functions using the GoMiner program were significantly changed (Table 1
). For example, groups of genes related to oxioreductase activity, cell proliferation, apoptosis, cell migration, and cell signaling were significantly changed in PAVECs and PAECs in response to shear stress (groups 1 and 2) and differentially expressed between PAVECs and PAECs in static and shear flow conditions (groups 3 and 4). Surprisingly, there were also many biological classifications that were significantly changed in these groups related to developmental and differentiation events, including morphogenesis, angiogenesis, skeletal and muscle development. A complete list of the changed gene categories for each comparison group is available in the GEO database. Several additional classes of functional groups related to endothelial physiology and pathology were identified, including the genes involved in skeletal and mesenchymal development.
|
|
Expression of Antioxidant and Antiinflammatory Gene Transcripts in Aortic Valve Endothelium
As shown in Table 2, PAVECs expressed a similar number of antioxidant genes but less inflammatory ones compared with PAECs. PAVECs expressed 5 of 6 antiinflammatory genes to a greater degree than PAECs and 10 of 13 proinflammatory genes to a lesser degree than PAECs. PAECs expressed interleukins (IL-1A, IL-8), connexin 43 (GJA1), activated leukocyte adhesion molecule, BMP-4, and type III collagen (COL3A1) to a greater degree than PAVECs, all of which have been shown to contribute to vascular endothelial cell inflammatory atherosclerosis (see references in Table IV, available online at http://atvb.ahajournals.org). Expression of prooxidant and antioxidant genes was more evenly distributed between the 2 cell types, with 9 antioxidant genes expressed to a greater degree in PAECs and 8 in PAVECs. Antioxidant and antiinflammatory genes were uniformly upregulated in response to shear stress in both cell types, including peroxiredoxins (PRDX1 and PRDX2) superoxide dismutase (SOD2), and cytochromes (CYP1A1, CYP1B1). Shear stress regulated proinflammatory and prooxidant genes in a more complex and heterogeneous manner.
|
Aortic and Aortic Valve Endothelial Cells Differentially Regulate Chondro/Osteogenic Genes
The analysis of significantly differentially expressed genes revealed an unexpected number of genes associated with chondrogenesis and osteogenesis (Table 2). Surprisingly, PAECs expressed 5 of 6 proosteogenic genes to a greater degree than PAVECs, whereas PAVECs expressed 6 of 8 chondrogenic genes to a greater degree than PAECs. PAVECs expressed CAD11 mRNA >100-fold greater than PAECs, whereas PAECs expressed POSTN mRNA >400-fold greater than PAVECs (Table 3). These POSTN and CAD11 array results were confirmed by Western blots using cell lysates. As shown in Figure 2, the 2 osteogenic proteins were expressed almost exclusively in 1 endothelial cell type. PAECs express 2 POSTN isoforms (75- and 77-kDa bands), whereas only the 75-kDa form was expressed in PAVECs (Figure 2A). The specificity of both bands has been confirmed by antigen competition blotting (Figure II, available online at http://atvb.ahajournals.org). Shear exposure downregulated the 77-kDa form but not the 75-kDa form, suggesting that the 77-kDa form corresponds to the shear-sensitive transcripts (Figure 2C). In contrast, CAD11 protein was highly expressed in PAVECs but not in PAECs (Figure 2B). The downregulation of CAD11 protein by shear in PAVEC was also confirmed (Figure 2D). These results are consistent with the notion that shear protects both endothelial cell types from chondro/osteogenic differentiation (Figure 2). The microarray and Western blot results of PAECs and PAVECs were further validated in vivo by immunostaining of normal porcine aorta and aortic valve (Figure 3). POSTN protein was easily detected in aortic endothelium (Figure 3P and 3Q) but not in valvular endothelium (Figure 3R through 3T). In contrast, CAD11 protein expression in aortic endothelium was not detectable (Figure 3K and 3L), whereas it was easily detected in valvular endothelium of fibrosa and ventricularis surfaces (Figure 3M through 3O).
|
| Discussion |
|---|
|
|
|---|
The similar regulation of oxidative and inflammatory genes by PAVECs and PAECs by shear stress suggests that hemodynamics may play a similarly important role in the pathogenesis of valvular diseases as it does in the vasculature. The hemodynamics experienced by the ventricular and aortic surfaces of aortic leaflets are distinctly different, with changes in flow direction on the aortic surface similar to those seen in vascular bifurcations.22 Mapping of the TIE1 promoter in mice localized to regions of vasculature that were atheroprone, including at bifurcations and on the aortic surface of the aortic valve,23 suggesting that both of these regions may be similarly susceptible to inflammatory disease. Early valvular lesions are primarily localized to the aortic (fibrosa) surface and characterized by endothelial expression of adhesion receptors such as VCAM1, intercellular adhesion molecule, and E-selectin.10,11 The more abundant expression of proinflammatory genes by PAECs compared with PAVECs (and less abundant expression of antiinflammatory genes by PAECs) suggests that aortic valve endothelial cells may be more intrinsically antiinflammatory than aortic endothelial cells.
More advanced lesions on both aortic valve leaflets and aortas are characterized by calcification of underlying tissue. Although calcification of valvular interstitial cells and vascular smooth muscle cells is mediated by apoptosis and enhanced with transforming growth factor-ß stimulation,24,25 the role of endothelial cells in this process is not completely understood. Increasing evidence suggests that endothelial cells may play a critical role in regulating this process. Endothelial cells in calcification-susceptible regions express calcification stimulating factors such as BMP-4 and reduced expression of inhibitory factors such as osteoprotegrin and osteopontin.21,26 We show shear stress downregulates initiators of calcification such as BMP-4 in vascular and valvular endothelial cells, as well as other genes, suggesting that hemodynamics may also mediate these events. We also discovered the almost exclusive expression of CAD11 in PAVECs and POSTN in PAECs, and both of these genes were significantly downregulated by steady shear stress. CAD11 is a member of the cadherin adhesion receptor family and is expressed in a variety of mesenchymal cells.27 Transfection of embryonic stem cells with CAD11 directly induces differentiation to chondrogenic and osteogenic phenotypes mediated by cell-cell contacts.28 Laminar shear inhibition of CAD11 may be critical for inhibition of calcification in valvular tissue. POSTN is a fibrous extracellular matrix protein with repeating fasciclin domains and 4 known isoforms, each of which appears to be a positive regulator of osteogenesis in preosteoblastic cells.29 Interestingly, POSTN is initially expressed in the mesenchyme of developing valve cushions, yet its expression is reduced in adult leaflets in comparison to the aorta by birth.30 We found 2 POSTN isoforms expressed in both endothelial cells, the 77-kDa isoform conforming to the microarray data (Figure 2; Figure II). We detected POSTN only in the aortic endothelium in vivo but not in the aortic valve endothelium. POSTN is dramatically increased during vascular injury and dilated cardiomyopathy and enhanced by BMP stimulation,31,32 suggesting its role in pathogenic cardiovascular remodeling. The downregulation of POSTN by shear stress in PAECs suggests that hemodynamics may also play a role in the regulation of POSTN in a calcific resistive manner in vascular tissue. It was also interesting to note that the preponderance of calcification genes expressed by PAVECs were chondrogenic, whereas osteogenic in PAECs. There have been rare occurrences of complete transformation of aortic valves into cartilage in humans,33,34 and cartilaginous tissue has been found in explants of bioprosthetic valves.35 The authors of these reports suggested that the formation of this cartilage was associated with tissue stress levels and represented a repair of ossified tissue. The interaction between valvular endothelial cells and interstitial cells leading to this transformation are unclear but suggest a unique result of pathogenic hemodynamic stimuli in valvular tissue.
In summary, transcriptional profile comparisons of valvular and vascular endothelial cells in different hemodynamic environments suggest that these cell types are distinctly different with respect to important biological functions but respond similarly to unidirectional shear stress to maintain a mature quiescent phenotype. The results of these studies raise important questions about endothelial phenotypes and the role hemodynamics play in regulating them, and the presented data provide a rich foundation from which more detailed investigation can progress.
| Acknowledgments |
|---|
Received June 15, 2005; accepted November 1, 2005.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. C. Liu, V. R. Joag, and A. I. Gotlieb The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology Am. J. Pathol., November 1, 2007; 171(5): 1407 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chang, D. Weiss, J. Suo, J. D. Vega, D. Giddens, W. R. Taylor, and H. Jo Bone Morphogenic Protein Antagonists Are Coexpressed With Bone Morphogenic Protein 4 in Endothelial Cells Exposed to Unstable Flow In Vitro in Mouse Aortas and in Human Coronary Arteries: Role of Bone Morphogenic Protein Antagonists in Inflammation and Atherosclerosis Circulation, September 11, 2007; 116(11): 1258 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Keller New Insights Into the Developmental Biomechanics of the Atrioventricular Valves Circ. Res., May 25, 2007; 100(10): 1399 - 1401. [Full Text] [PDF] |
||||
![]() |
J. T. Butcher, T. C. McQuinn, D. Sedmera, D. Turner, and R. R. Markwald Transitions in Early Embryonic Atrioventricular Valvular Function Correspond With Changes in Cushion Biomechanics That Are Predictable by Tissue Composition Circ. Res., May 25, 2007; 100(10): 1503 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Csiszar, N. Labinskyy, K. E. Smith, A. Rivera, E. N.T.P. Bakker, H. Jo, J. Gardner, Z. Orosz, and Z. Ungvari Downregulation of Bone Morphogenetic Protein 4 Expression in Coronary Arterial Endothelial Cells: Role of Shear Stress and the cAMP/Protein Kinase A Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Aird Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds Circ. Res., February 2, 2007; 100(2): 174 - 190. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |